Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro
暂无分享,去创建一个
[1] H. Okamoto. Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes , 1981, Molecular and Cellular Biochemistry.
[2] A. Slonim,et al. Protection against streptozotocin-induced diabetes by superoxide dismutase , 2005, Diabetologia.
[3] S. Sandler,et al. The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro , 1982, Diabetologia.
[4] D. Hearse,et al. Autoradiographic study of the distribution and cellular uptake of (14C)-streptozotocin in the rat , 1976, Diabetologia.
[5] D. Pipeleers,et al. Selective uptake of alloxan by pancreatic B-cells. , 1982, The Biochemical journal.
[6] I. Swenne. Effects of cyclic AMP on DNA replication and protein biosynthesis in fetal rat islets of Langerhans maintained in tissue culture , 1982, Bioscience reports.
[7] M. Buse,et al. Protective role of superoxide dismutase against diabetogenic drugs. , 1982, The Journal of clinical investigation.
[8] H. Okamoto,et al. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. , 1982, The Journal of biological chemistry.
[9] D. Pipeleers,et al. Determinants of the selective toxicity of alloxan to the pancreatic B cell. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[10] H. Okamoto,et al. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP–ribose) synthetase in pancreatic islets , 1981, Nature.
[11] M. Manning,et al. Diabetes Induced with Multiple Subdiabetogenic Doses of Streptozotocin: Lack of Protection by Exogenous Superoxide Dismutase , 1981, Diabetes.
[12] S. J. Cooperstein,et al. 15 – Action of Toxic Drugs on Islet Cells , 1981 .
[13] K. Grankvist. Mechanisms of alloxan diabetogenicity , 1981 .
[14] L. Boquist. A NEW HYPOTHESIS FOR ALLOXAN DIABETES , 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[15] P. J. Lewis,et al. The involvement of poly(ADP-ribose) polymerase in the degradation of NAD caused by gamma-radiation and N-methyl-N-nitrosourea. , 1979, European journal of biochemistry.
[16] L. Borg,et al. Effects in vitro of alloxan on the glucose metabolism of mouse pancreatic B-cells. , 1979, The Biochemical journal.
[17] P C Hanawalt,et al. DNA repair in bacteria and mammalian cells. , 1979, Annual review of biochemistry.
[18] E. Jacobson,et al. Inhibition of poly(ADP‐ribose) polymerase by methylated xanthines and cytokinins , 1978, FEBS letters.
[19] D. W. Mullins,et al. A putative role for nicotinamide adenine dinucleotide-promoted nuclear protein modification in the antitumor activity of N-methyl-N-nitrosourea. , 1977, Cancer research.
[20] W. Claycomb,et al. Poly(adenosine diphosphate ribose) polymerase activity and nicotinamide adenine dinucleotide in differentiating cardiac muscle. , 1976, The Biochemical journal.
[21] T. Anderson,et al. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide. , 1974, The Journal of clinical investigation.
[22] C. Hellerström,et al. Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide. , 1974, The Biochemical journal.
[23] C. Rerup,et al. Streptozotocin- and alloxan-diabetes in mice. , 1969, European journal of pharmacology.
[24] K. Taylor,et al. Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro. , 1968, The Biochemical journal.
[25] P. Schein,et al. The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity. , 1967, Cancer research.
[26] H. Krebs,et al. Untersuchungen uber die Harnstoffbildung im Tierkörper , 1932 .